03.25.13
Ixoreal Biomed, Hyderabad, India was recognized for its ingredient KSM-66as the “Best Botanical Ingredient” by the editors of Functional Ingredients magazine during Engredea as part of the Natural Products Expo West trade show in Anaheim, CA.
KSM-66, a form of ashwagandha utilizing proprietary and sustainable extraction methods, has the most extensive set of clinical trials of any ashwagandha extract available on the market. In total, there are five human clinical studies featuring KSM-66 Ashwagandha and two animal studies. From these studies, KSM-66 has been clinically documented to reduce stress and anxiety, enhance memory and cognition, increase endurance and strength and aid healthy sexual function. KSM-66 has an active research program with several more human studies in progress.
“A primary reason for KSM-66 getting this prestigious award is that it is the highest concentration full spectrum root-extract available on the market today, with the clinicals to back it up,” said Kartikeya Baldwa, director for Ixoreal Biomed. “KSM-66 is the sole product for Ixoreal Biomed. Because of our singular focus on ashwagandha, we are able to devote significant resources and achieve a high level of excellence that is difficult to match,” he added.
A key distinguishing characteristic of KSM-66 is that it uses only the roots of the ashwagandha plant, whereas some other extracts use the leaves as well. There are dozens of human studies documented in PubMed, virtually all of which use root-only extracts and no leaves. This is because the ashwagandha extract is conceptualized primarily as a root extract, not only in classical ayurveda textbooks, but also in the standard references like the Indian Pharmacopeia, British Pharmacopeia and the U.S. Pharmacopeia, all of whose specifications are based entirely on the root, the leaf is not included.
Mr. Baldwa adds, “KSM-66 represents a significant advancement for ashwagandha extracts featuring the highest concentration of withanolides from the root only. KSM-66 is also produced with a unique, sustainable extraction process without alcohol or synthetic solvents.”
KSM-66, a form of ashwagandha utilizing proprietary and sustainable extraction methods, has the most extensive set of clinical trials of any ashwagandha extract available on the market. In total, there are five human clinical studies featuring KSM-66 Ashwagandha and two animal studies. From these studies, KSM-66 has been clinically documented to reduce stress and anxiety, enhance memory and cognition, increase endurance and strength and aid healthy sexual function. KSM-66 has an active research program with several more human studies in progress.
“A primary reason for KSM-66 getting this prestigious award is that it is the highest concentration full spectrum root-extract available on the market today, with the clinicals to back it up,” said Kartikeya Baldwa, director for Ixoreal Biomed. “KSM-66 is the sole product for Ixoreal Biomed. Because of our singular focus on ashwagandha, we are able to devote significant resources and achieve a high level of excellence that is difficult to match,” he added.
A key distinguishing characteristic of KSM-66 is that it uses only the roots of the ashwagandha plant, whereas some other extracts use the leaves as well. There are dozens of human studies documented in PubMed, virtually all of which use root-only extracts and no leaves. This is because the ashwagandha extract is conceptualized primarily as a root extract, not only in classical ayurveda textbooks, but also in the standard references like the Indian Pharmacopeia, British Pharmacopeia and the U.S. Pharmacopeia, all of whose specifications are based entirely on the root, the leaf is not included.
Mr. Baldwa adds, “KSM-66 represents a significant advancement for ashwagandha extracts featuring the highest concentration of withanolides from the root only. KSM-66 is also produced with a unique, sustainable extraction process without alcohol or synthetic solvents.”
